Selected research
Industry Growth & Trends
Global Advanced Therapeutics Pharmaceutical Outsourcing Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Advanced Therapeutics Pharmaceutical Outsourcing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Advanced Therapeutics Pharmaceutical Outsourcing is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Advanced Therapeutics Pharmaceutical Outsourcing is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Advanced Therapeutics Pharmaceutical Outsourcing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Advanced Therapeutics Pharmaceutical Outsourcing market include Croda International Plc, Charles River Laboratories International, Inc., Catalent, Inc., QuintileslMS (IQVIA), Parexel International Corporation, ICON plc, PPD, Inc. (Thermo Fisher Scientific), LabCorp (Laboratory Corporation of America Holdings) and Syneos Health, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Advanced Therapeutics Pharmaceutical Outsourcing market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Advanced Therapeutics Pharmaceutical Outsourcing market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Advanced Therapeutics Pharmaceutical Outsourcing market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Advanced Therapeutics Pharmaceutical Outsourcing.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Advanced Therapeutics Pharmaceutical Outsourcing market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Advanced Therapeutics Pharmaceutical Outsourcing Market by Company
Croda International Plc
Charles River Laboratories International, Inc.
Catalent, Inc.
QuintileslMS (IQVIA)
Parexel International Corporation
ICON plc
PPD, Inc. (Thermo Fisher Scientific)
LabCorp (Laboratory Corporation of America Holdings)
Syneos Health
wuXi AppTecLonza Group
Piramal Pharma Solutions
SGS SA
Evotec SE
CMC Biologics (Now AGC Biologics)
Marken (A UPS Company)
Cytovance Biologics
Samsung Biologics
Advanced Therapeutics Pharmaceutical Outsourcing Segment by Type
Contract Research Organizations (CROs)
Contract Development and Manufacturing Organizations (CDMOs)
Advanced Therapeutics Pharmaceutical Outsourcing Segment by Application
Preclinical Services
Clinical Services
Commercial Manufacturing and Packaging
Advanced Therapeutics Pharmaceutical Outsourcing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Advanced Therapeutics Pharmaceutical Outsourcing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Advanced Therapeutics Pharmaceutical Outsourcing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Advanced Therapeutics Pharmaceutical Outsourcing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Advanced Therapeutics Pharmaceutical Outsourcing companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Contract Research Organizations (CROs)
- Contract Development and Manufacturing Organizations (CDMOs)
Applications
- Preclinical Services
- Clinical Services
- Commercial Manufacturing and Packaging
Companies covered
- Croda International Plc
- Charles River Laboratories International, Inc.
- Catalent, Inc.
- QuintileslMS (IQVIA)
- Parexel International Corporation
- ICON plc
- PPD, Inc. (Thermo Fisher Scientific)
- LabCorp (Laboratory Corporation of America Holdings)
- Syneos Health
- wuXi AppTecLonza Group
- Piramal Pharma Solutions
- SGS SA
- Evotec SE
- CMC Biologics (Now AGC Biologics)
- Marken (A UPS Company)
- Cytovance Biologics
- Samsung Biologics
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size by Region (2021-2032)
- 1.4.1 Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size by Region (2021-2026)
- 1.4.2 Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size by Region (2027-2032)
- 1.5 Key Regions Advanced Therapeutics Pharmaceutical Outsourcing Market Size (2021-2032)
- 1.5.1 North America Advanced Therapeutics Pharmaceutical Outsourcing Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Advanced Therapeutics Pharmaceutical Outsourcing Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Advanced Therapeutics Pharmaceutical Outsourcing Market Size Growth Rate (2021-2032)
- 1.5.4 South America Advanced Therapeutics Pharmaceutical Outsourcing Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Advanced Therapeutics Pharmaceutical Outsourcing Market Size Growth Rate (2021-2032)
2 Advanced Therapeutics Pharmaceutical Outsourcing Market by Type
- 2.1 Type Introduction
- 2.1.1 Contract Research Organizations (CROs)
- 2.1.2 Contract Development and Manufacturing Organizations (CDMOs)
- 2.2 Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size by Type
- 2.2.1 Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size Overview by Type (2021-2032)
- 2.2.2 Global Advanced Therapeutics Pharmaceutical Outsourcing Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size Forecasted by Type (2027-2032)
- 2.3 Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size by Regions
- 2.3.1 North America Advanced Therapeutics Pharmaceutical Outsourcing Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Advanced Therapeutics Pharmaceutical Outsourcing Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Advanced Therapeutics Pharmaceutical Outsourcing Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Advanced Therapeutics Pharmaceutical Outsourcing Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Advanced Therapeutics Pharmaceutical Outsourcing Market Size Breakdown by Type (2021-2026)
3 Advanced Therapeutics Pharmaceutical Outsourcing Market by Application
- 3.1 Type Introduction
- 3.1.1 Preclinical Services
- 3.1.2 Clinical Services
- 3.1.3 Commercial Manufacturing and Packaging
- 3.2 Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size by Application
- 3.2.1 Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size Overview by Application (2021-2032)
- 3.2.2 Global Advanced Therapeutics Pharmaceutical Outsourcing Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size Forecasted by Application (2027-2032)
- 3.3 Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size by Regions
- 3.3.1 North America Advanced Therapeutics Pharmaceutical Outsourcing Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Advanced Therapeutics Pharmaceutical Outsourcing Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Advanced Therapeutics Pharmaceutical Outsourcing Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Advanced Therapeutics Pharmaceutical Outsourcing Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Advanced Therapeutics Pharmaceutical Outsourcing Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Advanced Therapeutics Pharmaceutical Outsourcing Industry Trends
- 4.2 Advanced Therapeutics Pharmaceutical Outsourcing Industry Drivers
- 4.3 Advanced Therapeutics Pharmaceutical Outsourcing Industry Opportunities and Challenges
- 4.4 Advanced Therapeutics Pharmaceutical Outsourcing Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Advanced Therapeutics Pharmaceutical Outsourcing Revenue (2021-2026)
- 5.2 Global Advanced Therapeutics Pharmaceutical Outsourcing Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Advanced Therapeutics Pharmaceutical Outsourcing Key Company Headquarters & Area Served
- 5.4 Global Advanced Therapeutics Pharmaceutical Outsourcing Company, Product Type & Application
- 5.5 Global Advanced Therapeutics Pharmaceutical Outsourcing Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Advanced Therapeutics Pharmaceutical Outsourcing Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Advanced Therapeutics Pharmaceutical Outsourcing Players Market Share by Revenue in 2025
- 5.6.3 2025 Advanced Therapeutics Pharmaceutical Outsourcing Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Croda International Plc
- 6.1.1 Croda International Plc Company Information
- 6.1.2 Croda International Plc Business Overview
- 6.1.3 Croda International Plc Advanced Therapeutics Pharmaceutical Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Croda International Plc Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
- 6.1.5 Croda International Plc Recent Developments
- 6.2 Charles River Laboratories International, Inc.
- 6.2.1 Charles River Laboratories International, Inc. Company Information
- 6.2.2 Charles River Laboratories International, Inc. Business Overview
- 6.2.3 Charles River Laboratories International, Inc. Advanced Therapeutics Pharmaceutical Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Charles River Laboratories International, Inc. Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
- 6.2.5 Charles River Laboratories International, Inc. Recent Developments
- 6.3 Catalent, Inc.
- 6.3.1 Catalent, Inc. Company Information
- 6.3.2 Catalent, Inc. Business Overview
- 6.3.3 Catalent, Inc. Advanced Therapeutics Pharmaceutical Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Catalent, Inc. Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
- 6.3.5 Catalent, Inc. Recent Developments
- 6.4 QuintileslMS (IQVIA)
- 6.4.1 QuintileslMS (IQVIA) Company Information
- 6.4.2 QuintileslMS (IQVIA) Business Overview
- 6.4.3 QuintileslMS (IQVIA) Advanced Therapeutics Pharmaceutical Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 QuintileslMS (IQVIA) Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
- 6.4.5 QuintileslMS (IQVIA) Recent Developments
- 6.5 Parexel International Corporation
- 6.5.1 Parexel International Corporation Company Information
- 6.5.2 Parexel International Corporation Business Overview
- 6.5.3 Parexel International Corporation Advanced Therapeutics Pharmaceutical Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Parexel International Corporation Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
- 6.5.5 Parexel International Corporation Recent Developments
- 6.6 ICON plc
- 6.6.1 ICON plc Company Information
- 6.6.2 ICON plc Business Overview
- 6.6.3 ICON plc Advanced Therapeutics Pharmaceutical Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 ICON plc Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
- 6.6.5 ICON plc Recent Developments
- 6.7 PPD, Inc. (Thermo Fisher Scientific)
- 6.7.1 PPD, Inc. (Thermo Fisher Scientific) Company Information
- 6.7.2 PPD, Inc. (Thermo Fisher Scientific) Business Overview
- 6.7.3 PPD, Inc. (Thermo Fisher Scientific) Advanced Therapeutics Pharmaceutical Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 PPD, Inc. (Thermo Fisher Scientific) Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
- 6.7.5 PPD, Inc. (Thermo Fisher Scientific) Recent Developments
- 6.8 LabCorp (Laboratory Corporation of America Holdings)
- 6.8.1 LabCorp (Laboratory Corporation of America Holdings) Company Information
- 6.8.2 LabCorp (Laboratory Corporation of America Holdings) Business Overview
- 6.8.3 LabCorp (Laboratory Corporation of America Holdings) Advanced Therapeutics Pharmaceutical Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 LabCorp (Laboratory Corporation of America Holdings) Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
- 6.8.5 LabCorp (Laboratory Corporation of America Holdings) Recent Developments
- 6.9 Syneos Health
- 6.9.1 Syneos Health Company Information
- 6.9.2 Syneos Health Business Overview
- 6.9.3 Syneos Health Advanced Therapeutics Pharmaceutical Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Syneos Health Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
- 6.9.5 Syneos Health Recent Developments
- 6.10 wuXi AppTecLonza Group
- 6.10.1 wuXi AppTecLonza Group Company Information
- 6.10.2 wuXi AppTecLonza Group Business Overview
- 6.10.3 wuXi AppTecLonza Group Advanced Therapeutics Pharmaceutical Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 wuXi AppTecLonza Group Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
- 6.10.5 wuXi AppTecLonza Group Recent Developments
- 6.11 Piramal Pharma Solutions
- 6.11.1 Piramal Pharma Solutions Company Information
- 6.11.2 Piramal Pharma Solutions Business Overview
- 6.11.3 Piramal Pharma Solutions Advanced Therapeutics Pharmaceutical Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Piramal Pharma Solutions Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
- 6.11.5 Piramal Pharma Solutions Recent Developments
- 6.12 SGS SA
- 6.12.1 SGS SA Company Information
- 6.12.2 SGS SA Business Overview
- 6.12.3 SGS SA Advanced Therapeutics Pharmaceutical Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 SGS SA Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
- 6.12.5 SGS SA Recent Developments
- 6.13 Evotec SE
- 6.13.1 Evotec SE Company Information
- 6.13.2 Evotec SE Business Overview
- 6.13.3 Evotec SE Advanced Therapeutics Pharmaceutical Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Evotec SE Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
- 6.13.5 Evotec SE Recent Developments
- 6.14 CMC Biologics (Now AGC Biologics)
- 6.14.1 CMC Biologics (Now AGC Biologics) Company Information
- 6.14.2 CMC Biologics (Now AGC Biologics) Business Overview
- 6.14.3 CMC Biologics (Now AGC Biologics) Advanced Therapeutics Pharmaceutical Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 CMC Biologics (Now AGC Biologics) Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
- 6.14.5 CMC Biologics (Now AGC Biologics) Recent Developments
- 6.15 Marken (A UPS Company)
- 6.15.1 Marken (A UPS Company) Company Information
- 6.15.2 Marken (A UPS Company) Business Overview
- 6.15.3 Marken (A UPS Company) Advanced Therapeutics Pharmaceutical Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Marken (A UPS Company) Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
- 6.15.5 Marken (A UPS Company) Recent Developments
- 6.16 Cytovance Biologics
- 6.16.1 Cytovance Biologics Company Information
- 6.16.2 Cytovance Biologics Business Overview
- 6.16.3 Cytovance Biologics Advanced Therapeutics Pharmaceutical Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Cytovance Biologics Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
- 6.16.5 Cytovance Biologics Recent Developments
- 6.17 Samsung Biologics
- 6.17.1 Samsung Biologics Company Information
- 6.17.2 Samsung Biologics Business Overview
- 6.17.3 Samsung Biologics Advanced Therapeutics Pharmaceutical Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 Samsung Biologics Advanced Therapeutics Pharmaceutical Outsourcing Product Portfolio
- 6.17.5 Samsung Biologics Recent Developments
7 North America
- 7.1 North America Advanced Therapeutics Pharmaceutical Outsourcing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Advanced Therapeutics Pharmaceutical Outsourcing Market Size by Country (2021-2026)
- 7.3 North America Advanced Therapeutics Pharmaceutical Outsourcing Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Advanced Therapeutics Pharmaceutical Outsourcing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Advanced Therapeutics Pharmaceutical Outsourcing Market Size by Country (2021-2026)
- 8.3 Europe Advanced Therapeutics Pharmaceutical Outsourcing Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Advanced Therapeutics Pharmaceutical Outsourcing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Advanced Therapeutics Pharmaceutical Outsourcing Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Advanced Therapeutics Pharmaceutical Outsourcing Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Advanced Therapeutics Pharmaceutical Outsourcing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Advanced Therapeutics Pharmaceutical Outsourcing Market Size by Country (2021-2026)
- 10.3 South America Advanced Therapeutics Pharmaceutical Outsourcing Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Advanced Therapeutics Pharmaceutical Outsourcing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Advanced Therapeutics Pharmaceutical Outsourcing Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Advanced Therapeutics Pharmaceutical Outsourcing Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst